Literature DB >> 15733222

Model systems based on experimental animals for studies on drug metabolism in man: (mini)pig cytochromes P450 3A29 and 2E1.

Eva Anzenbacherová1, Jana Baranová, Roman Zuber, Alena Pechová, Pavel Anzenbacher, Pavel Soucek, Jirina Martínková.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733222     DOI: 10.1111/j.1742-7843.2005.pto960316.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


× No keyword cloud information.
  5 in total

1.  Establishment and characteristics of Gottingen minipig skin in organ culture and monolayer cell culture: relevance to drug safety testing.

Authors:  Michael K Dame; Diana M Spahlinger; Marissa DaSilva; Patricia Perone; Robert Dunstan; James Varani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-06-21       Impact factor: 2.416

Review 2.  A physiologically based pharmacokinetic model of the minipig: data compilation and model implementation.

Authors:  Claudia Suenderhauf; Neil Parrott
Journal:  Pharm Res       Date:  2012-11-21       Impact factor: 4.200

Review 3.  Porcine cytochrome P450 3A: current status on expression and regulation.

Authors:  Martin Krøyer Rasmussen
Journal:  Arch Toxicol       Date:  2020-03-14       Impact factor: 5.153

4.  Characterization of Porcine Hepatic and Intestinal Drug Metabolizing CYP450: Comparison with Human Orthologues from A Quantitative, Activity and Selectivity Perspective.

Authors:  Wim Schelstraete; Laura De Clerck; Elisabeth Govaert; Joske Millecam; Mathias Devreese; Dieter Deforce; Jan Van Bocxlaer; Siska Croubels
Journal:  Sci Rep       Date:  2019-06-25       Impact factor: 4.379

Review 5.  The Neonatal and Juvenile Pig in Pediatric Drug Discovery and Development.

Authors:  Miriam Ayuso; Laura Buyssens; Marina Stroe; Allan Valenzuela; Karel Allegaert; Anne Smits; Pieter Annaert; Antonius Mulder; Sebastien Carpentier; Chris Van Ginneken; Steven Van Cruchten
Journal:  Pharmaceutics       Date:  2020-12-30       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.